Zinke-Cerwenka, W; Eibl, M; Sill, H; Hofler, G; Staber, P; Linkesch, W.
Continuous molecular response after discontinuation of imatinib mesylate following relapse after non-myeloablative allogeneic stem cell transplantation for CML
BONE MARROW TRANSPLANT 2004 33: S348-S348.
Web of Science